Table 3.
Outcome | N (%) | HR | 95% CI | p-value |
---|---|---|---|---|
Related matched donor | 307 (36%) | |||
Early respiratory failure* | 1.83 | 1.18 to 2.84 | 0.007 | |
Relapse** | 1.21 | 0.92 to 1.60 | 0.17 | |
Non-relapse mortality‡ | 0.99 | 0.77 to 1.29 | 0.97 | |
Unrelated matched donor | 311 (37%) | |||
Early respiratory failure* | 1.46 | 1.02 to 2.09 | 0.04 | |
Relapse** | 1.44 | 1.04 to 2.01 | 0.03 | |
Non-relapse mortality‡ | 0.91 | 0.74 to 1.12 | 0.38 |
Adjusted for age, gender, smoking status, conditioning regimen, acute GVHD
Adjusted for age, gender, smoking status, conditioning regimen, disease risk, acute and chronic GVHD
Adjusted for age, gender, smoking status, conditioning regimen, stem cell source, PAM score, acute and chronic GVHD